Understanding Farydak® (panobinostat) capsules

Farydak is the first histone deacetylase (HDAC) inhibitor approved for use in treating myeloma. Farydak is taken in capsule form in combination with Velcade® (bortezomib) and dexamethasone by patients who have already been treated with Velcade and an immunomodulatory drug.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.